Syncona Portfolio Ltd Long-Term Concentrated

CIK: 0001725042 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $62,999 (100.0% shares, 0.0% debt)

Holdings (4)

AUTL AUTOLUS THERAPEUTICS PLC 64.4%

Value ($000) $40,559 Shares 21,346,829 Est. Cost $3.03 Unrealized —

— FREELINE THERAPEUTICS HLDGS 16.6%

Value ($000) $10,451 Shares 21,997,620 Est. Cost $0.50 Unrealized —

— ACHILLES THERAPEUTICS PLC 15.8%

Value ($000) $9,978 Shares 11,086,909 Est. Cost $5.01 Unrealized —

ADAPY ADAPTIMMUNE THERAPEUTICS PLC 3.2%

Value ($000) $2,011 Shares 1,377,294 Est. Cost $3.75 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
AUTL	AUTOLUS THERAPEUTICS PLC	21,346,829	$40,559	64.4%	$3.03	—	SPON ADS	05280R100
—	FREELINE THERAPEUTICS HLDGS	21,997,620	$10,451	16.6%	$0.50	—	SPONSORED ADS	35655L107
—	ACHILLES THERAPEUTICS PLC	11,086,909	$9,978	15.8%	$5.01	—	SPONSORED ADS	00449L102
ADAPY	ADAPTIMMUNE THERAPEUTICS PLC	1,377,294	$2,011	3.2%	$3.75	—	SPONDS ADR	00653A107